5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow Chronobiology Disorders: new trials by email Literature Review of Chronobiology Disorders trials Research Report on Chronobiology Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents tasimelteon - Circadian Rhythm Sleep Disorders, Non-24 Hour Sleep-Wake Disorder | Phase 1 | Completed | Vanda Pharmaceuticals | 24 | 2016-10-04 | 2024-03-21 |
| Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances Circadin 2 mg, Circadin 10 mg - Sleep Problems | Phase 1 | Completed | Neurim Pharmaceuticals Ltd. | 16 | 2013-03-01 | 2014-04-04 |
| Sleep Enhancement Training Study for Novice Shiftworkers Sleep Enhancement Training System, NIOSH shiftwork booklet - Shift-Work Sleep Disorder | Phase 1 | Completed | University of California, San Francisco | 20 | 2008-11-01 | 2010-06-23 |
| Sleep Enhancement Training Study for Experienced Shiftworkers NIOSH shiftwork booklet, Sleep Enhancement Training System - Shift-Work Sleep Disorder | Phase 1 | Completed | University of California, San Francisco | 32 | 2008-11-01 | 2010-06-23 |
| Treatment Strategies for Children With Smith-Magenis Syndrome dTR Melatonin (NIH CC PDS), Phototherapy (Bright Light), Melatonin CR - Developmental Delay Disorders, Chromosome Deletion | Phase 1 | Completed | National Human Genome Research Institute (NHGRI) | 23 | 2007-07-17 | 2019-12-12 |
Sleep Disorders, Circadian Rhythm (4) · Smith-Magenis Syndrome (3) · Autism Spectrum Disorder (2) · Parasomnias (2) · Angelman Syndrome (1) · Chromosome Deletion (1) · Developmental Disabilities (1) · Intellectual Disability (1) · Self-Injurious Behavior (1) · Sleep Wake Disorders (1) · Tuberous Sclerosis (1)
Mental Disorders (5) · Nervous System Diseases (5) · Dyssomnias (4) · Occupational Diseases (4) · Sleep Wake Disorders (4) · Abnormalities, Multiple (3) · Chromosome Disorders (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Neurodevelopmental Disorders (3) · Child Development Disorders, Pervasive (2) · Aneuploidy (1) · Behavior (1)
Melatonin (1) · Phototherapy (1) · tasimelteon (1)
University of California, San Francisco (2) · National Human Genome Research Institute (NHGRI) (1) · Neurim Pharmaceuticals Ltd. (1) · Vanda Pharmaceuticals (1)
United States (4) · Netherlands (1)
Christopher R Alsten, PhD (1) · Christopher R. Alsten, PhD (1) · William A Gahl, M.D. (1)
R43NR010688 (1)